Gene Activity List

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 81 of 1714:
71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91
Gene Compound Assay Inh Ic50 Ki View
sodium channel, voltage-gated, type XI, alpha NORETHINDRONE Sodium Channel, Site 2 63% 15.37uM 13.78uM View
sodium channel, voltage-gated, type I, beta NORETHINDRONE Sodium Channel, Site 2 63% 15.37uM 13.78uM View
sodium channel, voltage-gated, type 10, alpha polypeptide NORETHINDRONE Sodium Channel, Site 2 63% 15.37uM 13.78uM View
sodium channel, voltage-gated, type IV, alpha polypeptide NORETHINDRONE Sodium Channel, Site 2 63% 15.37uM 13.78uM View
sodium channel, voltage-gated, type V, alpha polypeptide NORETHINDRONE Sodium Channel, Site 2 63% 15.37uM 13.78uM View
sodium channel, voltage-gated, type II, beta NORETHINDRONE Sodium Channel, Site 2 63% 15.37uM 13.78uM View
sodium channel, nonvoltage-gated 1 alpha NORETHINDRONE Sodium Channel, Site 2 63% 15.37uM 13.78uM View
sodium channel, nonvoltage-gated 1 gamma NORETHINDRONE Sodium Channel, Site 2 63% 15.37uM 13.78uM View
sodium channel, nonvoltage-gated 1 beta NORETHINDRONE Sodium Channel, Site 2 63% 15.37uM 13.78uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide NORETHINDRONE Sodium Channel, Site 2 63% 15.37uM 13.78uM View
sodium channel, voltage-gated, type XI, alpha NORETHINDRONE Sodium Channel, Site 2 63% 15.37uM 13.78uM View
sodium channel, nonvoltage-gated 1, gamma NORETHINDRONE Sodium Channel, Site 2 63% 15.37uM 13.78uM View
sodium channel, nonvoltage-gated 1, delta NORETHINDRONE Sodium Channel, Site 2 63% 15.37uM 13.78uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) NORETHINDRONE Sodium Channel, Site 2 63% 15.37uM 13.78uM View
sodium channel, nonvoltage-gated 1 alpha NORETHINDRONE Sodium Channel, Site 2 63% 15.37uM 13.78uM View
sodium channel, voltage-gated, type X, alpha NORETHINDRONE Sodium Channel, Site 2 63% 15.37uM 13.78uM View
sodium channel, voltage-gated, type IX, alpha NORETHINDRONE Sodium Channel, Site 2 63% 15.37uM 13.78uM View
5-hydroxytryptamine (serotonin) receptor 2B PRIMAQUINE Serotonin 5-HT2B 63% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 2 RESVERATROL Cyclooxygenase COX-2 63% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) RESVERATROL Cyclooxygenase COX-2 63% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 PHENTOLAMINE Serotonin Transporter 63% NoneNone NoneNone View
5-hydroxytryptamine receptor 6 RALOXIFENE Serotonin 5-HT6 63% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta TIBOLONE Sodium Channel, Site 2 63% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha TIBOLONE Sodium Channel, Site 2 63% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel, voltage-gated, type II, alpha 2 DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel, voltage-gated, type I, beta DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel, voltage-gated, type I, alpha DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel, voltage-gated, type IV, beta DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel associated protein 1 DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel associated protein 2 DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel, voltage-gated, type III, beta DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
sodium channel, voltage-gated, type I, alpha DEXCHLORPHENIRAMINE Sodium Channel, Site 2 63% 15.017uM 13.464uM View
monoamine oxidase A CIGLITAZONE Monoamine Oxidase MAOA 63% 29.193uM NoneNone View
monoamine oxidase A CIGLITAZONE Monoamine Oxidase MAOA 63% 29.193uM NoneNone View
adrenergic receptor, alpha 2a LEVAMISOLE Imidazoline I2, Central 63% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) LEVAMISOLE Imidazoline I2, Central 63% NoneNone NoneNone View
dopamine receptor D3 AJMALINE Dopamine D3 63% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2C BACITRACIN Serotonin 5-HT2C 63% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 MC 258714 Dopamine Transporter 63% NoneNone NoneNone View
cannabinoid receptor 1 (brain) AMLODIPINE Cannabinoid CB1 63% NoneNone NoneNone View
purinergic receptor P2X, ligand-gated ion channel, 1 TANNIC ACID Purinergic P2X 63% NoneNone NoneNone View
purinergic receptor P2X, ligand-gated ion channel, 7 TANNIC ACID Purinergic P2X 63% NoneNone NoneNone View
purinergic receptor P2X-like 1, orphan receptor TANNIC ACID Purinergic P2X 63% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 AMITRIPTYLINE Dopamine Transporter 63% NoneNone NoneNone View
adrenergic receptor, beta 1 AMIODARONE Adrenergic beta1 63% 43.643uM 25.202uM View
adrenergic, beta-1-, receptor AMIODARONE Adrenergic beta1 63% 43.643uM 25.202uM View
arachidonate 15-lipoxygenase, second type CHLORPROMAZINE Lipoxygenase 15-LO 63% 15.951uM NoneNone View
arachidonate 15-lipoxygenase CHLORPROMAZINE Lipoxygenase 15-LO 63% 15.951uM NoneNone View
arachidonate 15-lipoxygenase CHLORPROMAZINE Lipoxygenase 15-LO 63% 15.951uM NoneNone View
calcium channel, voltage-dependent, beta 2 subunit MEPAZINE Calcium Channel Type L, Benzothiazepine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit MEPAZINE Calcium Channel Type L, Benzothiazepine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit MEPAZINE Calcium Channel Type L, Benzothiazepine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit MEPAZINE Calcium Channel Type L, Benzothiazepine 62% NoneNone NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) BENZO[A]PYRENE Protein Tyrosine Kinase, HER2 Receptor 62% 41.503uM NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) BENZO[A]PYRENE Protein Tyrosine Kinase, HER2 Receptor 62% 41.503uM NoneNone View
melanocortin 5 receptor CIGLITAZONE Melanocortin MC5 62% 28.621uM 26.848uM View
Cytochrom P450-2D6 monooxygenase DEXCHLORPHENIRAMINE CYP450-2D6 Inhibition 62% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 DANAZOL Calcium Channel Type L, Dihydropyridine 62% 19.61uM 12.606uM View
calcium channel, voltage-dependent, gamma subunit 7 DANAZOL Calcium Channel Type L, Dihydropyridine 62% 19.61uM 12.606uM View
calcium channel, voltage-dependent, gamma subunit 6 DANAZOL Calcium Channel Type L, Dihydropyridine 62% 19.61uM 12.606uM View
calcium channel, voltage-dependent, gamma subunit 5 DANAZOL Calcium Channel Type L, Dihydropyridine 62% 19.61uM 12.606uM View
calcium channel, voltage-dependent, gamma subunit 4 DANAZOL Calcium Channel Type L, Dihydropyridine 62% 19.61uM 12.606uM View
calcium channel, voltage-dependent, gamma subunit 3 DANAZOL Calcium Channel Type L, Dihydropyridine 62% 19.61uM 12.606uM View
calcium channel, voltage-dependent, gamma subunit 2 DANAZOL Calcium Channel Type L, Dihydropyridine 62% 19.61uM 12.606uM View
calcium channel, voltage-dependent, gamma subunit 1 DANAZOL Calcium Channel Type L, Dihydropyridine 62% 19.61uM 12.606uM View
calcium channel, voltage-dependent, beta 4 subunit DANAZOL Calcium Channel Type L, Dihydropyridine 62% 19.61uM 12.606uM View
calcium channel, voltage-dependent, beta 3 subunit DANAZOL Calcium Channel Type L, Dihydropyridine 62% 19.61uM 12.606uM View
calcium channel, voltage-dependent, beta 2 subunit DANAZOL Calcium Channel Type L, Dihydropyridine 62% 19.61uM 12.606uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit DANAZOL Calcium Channel Type L, Dihydropyridine 62% 19.61uM 12.606uM View
calcium channel, voltage-dependent, alpha 1F subunit DANAZOL Calcium Channel Type L, Dihydropyridine 62% 19.61uM 12.606uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit DANAZOL Calcium Channel Type L, Dihydropyridine 62% 19.61uM 12.606uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit DANAZOL Calcium Channel Type L, Dihydropyridine 62% 19.61uM 12.606uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit DANAZOL Calcium Channel Type L, Dihydropyridine 62% 19.61uM 12.606uM View
calcium channel, voltage-dependent, beta 1 subunit DANAZOL Calcium Channel Type L, Dihydropyridine 62% 19.61uM 12.606uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit DANAZOL Calcium Channel Type L, Dihydropyridine 62% 19.61uM 12.606uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit DANAZOL Calcium Channel Type L, Dihydropyridine 62% 19.61uM 12.606uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 DANAZOL Calcium Channel Type L, Dihydropyridine 62% 19.61uM 12.606uM View
adrenergic receptor, alpha 2a DANAZOL Adrenergic alpha2A 62% 18.328uM 6.873uM View
calcium channel, voltage-dependent, gamma subunit 8 MIFEPRISTONE Calcium Channel Type L, Benzothiazepine 62% 29.049uM 25.821uM View
calcium channel, voltage-dependent, gamma subunit 7 MIFEPRISTONE Calcium Channel Type L, Benzothiazepine 62% 29.049uM 25.821uM View
calcium channel, voltage-dependent, gamma subunit 6 MIFEPRISTONE Calcium Channel Type L, Benzothiazepine 62% 29.049uM 25.821uM View
calcium channel, voltage-dependent, gamma subunit 5 MIFEPRISTONE Calcium Channel Type L, Benzothiazepine 62% 29.049uM 25.821uM View
calcium channel, voltage-dependent, gamma subunit 4 MIFEPRISTONE Calcium Channel Type L, Benzothiazepine 62% 29.049uM 25.821uM View
calcium channel, voltage-dependent, gamma subunit 3 MIFEPRISTONE Calcium Channel Type L, Benzothiazepine 62% 29.049uM 25.821uM View
calcium channel, voltage-dependent, gamma subunit 2 MIFEPRISTONE Calcium Channel Type L, Benzothiazepine 62% 29.049uM 25.821uM View
calcium channel, voltage-dependent, gamma subunit 1 MIFEPRISTONE Calcium Channel Type L, Benzothiazepine 62% 29.049uM 25.821uM View
calcium channel, voltage-dependent, beta 4 subunit MIFEPRISTONE Calcium Channel Type L, Benzothiazepine 62% 29.049uM 25.821uM View
calcium channel, voltage-dependent, beta 3 subunit MIFEPRISTONE Calcium Channel Type L, Benzothiazepine 62% 29.049uM 25.821uM View
calcium channel, voltage-dependent, beta 2 subunit MIFEPRISTONE Calcium Channel Type L, Benzothiazepine 62% 29.049uM 25.821uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit MIFEPRISTONE Calcium Channel Type L, Benzothiazepine 62% 29.049uM 25.821uM View
calcium channel, voltage-dependent, alpha 1F subunit MIFEPRISTONE Calcium Channel Type L, Benzothiazepine 62% 29.049uM 25.821uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit MIFEPRISTONE Calcium Channel Type L, Benzothiazepine 62% 29.049uM 25.821uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit MIFEPRISTONE Calcium Channel Type L, Benzothiazepine 62% 29.049uM 25.821uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit MIFEPRISTONE Calcium Channel Type L, Benzothiazepine 62% 29.049uM 25.821uM View
sodium channel, voltage-gated, type V, alpha polypeptide VINBLASTINE Sodium Channel, Site 2 62% 25.191uM 22.585uM View
sodium channel, voltage-gated, type II, beta VINBLASTINE Sodium Channel, Site 2 62% 25.191uM 22.585uM View
sodium channel, nonvoltage-gated 1 alpha VINBLASTINE Sodium Channel, Site 2 62% 25.191uM 22.585uM View
sodium channel, nonvoltage-gated 1 gamma VINBLASTINE Sodium Channel, Site 2 62% 25.191uM 22.585uM View
sodium channel, nonvoltage-gated 1 beta VINBLASTINE Sodium Channel, Site 2 62% 25.191uM 22.585uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide VINBLASTINE Sodium Channel, Site 2 62% 25.191uM 22.585uM View
sodium channel, voltage-gated, type XI, alpha VINBLASTINE Sodium Channel, Site 2 62% 25.191uM 22.585uM View
sodium channel, nonvoltage-gated 1, gamma VINBLASTINE Sodium Channel, Site 2 62% 25.191uM 22.585uM View
sodium channel, nonvoltage-gated 1, delta VINBLASTINE Sodium Channel, Site 2 62% 25.191uM 22.585uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) VINBLASTINE Sodium Channel, Site 2 62% 25.191uM 22.585uM View
sodium channel, nonvoltage-gated 1 alpha VINBLASTINE Sodium Channel, Site 2 62% 25.191uM 22.585uM View
sodium channel associated protein 1 PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel associated protein 2 PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, voltage-gated, type III, beta PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, voltage-gated, type I, alpha PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, voltage-gated, type IX, alpha PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, voltage-gated, type VII, alpha PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
amiloride-sensitive cation channel 5, intestinal PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, voltage-gated, type III, beta PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, voltage-gated, type XI, alpha PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, voltage-gated, type I, beta PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, voltage-gated, type 10, alpha polypeptide PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, voltage-gated, type IV, alpha polypeptide PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, voltage-gated, type V, alpha polypeptide PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, voltage-gated, type II, beta PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, nonvoltage-gated 1 alpha PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, nonvoltage-gated 1 gamma PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, nonvoltage-gated 1 beta PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, voltage-gated, type XI, alpha PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, nonvoltage-gated 1, gamma PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, nonvoltage-gated 1, delta PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, nonvoltage-gated 1 alpha PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, voltage-gated, type X, alpha PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, voltage-gated, type IX, alpha PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, voltage gated, type VIII, alpha PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, voltage-gated, type VII, alpha PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, voltage-gated, type IV, beta PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, voltage-gated, type IV, alpha PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, voltage-gated, type III, alpha PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, voltage-gated, type II, beta PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, voltage-gated, type II, alpha 2 PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, voltage-gated, type I, beta PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
sodium channel, voltage-gated, type I, alpha PROPOFOL Sodium Channel, Site 2 61% 25.647uM 22.994uM View
adrenergic receptor, alpha 1d (Non-specific probe) CLOMIPHENE Adrenergic alpha1D 61% NoneNone NoneNone View
thromboxane A synthase 1 GLIMEPIRIDE Thromboxane Synthetase 61% NoneNone NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) GLIMEPIRIDE Thromboxane Synthetase 61% NoneNone NoneNone View
thromboxane A synthase 1 HALOPROGIN Thromboxane Synthetase 61% NoneNone NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) HALOPROGIN Thromboxane Synthetase 61% NoneNone NoneNone View
adrenergic receptor, alpha 2a DIPHENHYDRAMINE Imidazoline I2, Central 61% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 CELECOXIB Calcium Channel Type L, Dihydropyridine 64% 24.601uM 15.815uM View
calcium channel, voltage-dependent, gamma subunit 6 CELECOXIB Calcium Channel Type L, Dihydropyridine 64% 24.601uM 15.815uM View
calcium channel, voltage-dependent, gamma subunit 5 CELECOXIB Calcium Channel Type L, Dihydropyridine 64% 24.601uM 15.815uM View
calcium channel, voltage-dependent, gamma subunit 4 CELECOXIB Calcium Channel Type L, Dihydropyridine 64% 24.601uM 15.815uM View
calcium channel, voltage-dependent, gamma subunit 3 CELECOXIB Calcium Channel Type L, Dihydropyridine 64% 24.601uM 15.815uM View
calcium channel, voltage-dependent, gamma subunit 2 CELECOXIB Calcium Channel Type L, Dihydropyridine 64% 24.601uM 15.815uM View
calcium channel, voltage-dependent, gamma subunit 1 CELECOXIB Calcium Channel Type L, Dihydropyridine 64% 24.601uM 15.815uM View
calcium channel, voltage-dependent, beta 4 subunit CELECOXIB Calcium Channel Type L, Dihydropyridine 64% 24.601uM 15.815uM View
calcium channel, voltage-dependent, beta 3 subunit CELECOXIB Calcium Channel Type L, Dihydropyridine 64% 24.601uM 15.815uM View
calcium channel, voltage-dependent, beta 2 subunit CELECOXIB Calcium Channel Type L, Dihydropyridine 64% 24.601uM 15.815uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit CELECOXIB Calcium Channel Type L, Dihydropyridine 64% 24.601uM 15.815uM View
calcium channel, voltage-dependent, alpha 1F subunit CELECOXIB Calcium Channel Type L, Dihydropyridine 64% 24.601uM 15.815uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit CELECOXIB Calcium Channel Type L, Dihydropyridine 64% 24.601uM 15.815uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit CELECOXIB Calcium Channel Type L, Dihydropyridine 64% 24.601uM 15.815uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit CELECOXIB Calcium Channel Type L, Dihydropyridine 64% 24.601uM 15.815uM View
calcium channel, voltage-dependent, beta 1 subunit CELECOXIB Calcium Channel Type L, Dihydropyridine 64% 24.601uM 15.815uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit CELECOXIB Calcium Channel Type L, Dihydropyridine 64% 24.601uM 15.815uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit CELECOXIB Calcium Channel Type L, Dihydropyridine 64% 24.601uM 15.815uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 CELECOXIB Calcium Channel Type L, Dihydropyridine 64% 24.601uM 15.815uM View
mitogen activated protein kinase 14 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN Protein Serine/Threonine Kinase, p38alpha 64% NoneNone NoneNone View
mitogen-activated protein kinase 14 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN Protein Serine/Threonine Kinase, p38alpha 64% NoneNone NoneNone View
histamine receptor H 1 U-78517F Histamine H1, Central 64% 14.791uM 1.718uM View
cannabinoid receptor 1 (brain) AMOXAPINE Cannabinoid CB1 64% NoneNone NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) CLOTRIMAZOLE Protein Tyrosine Kinase, HER2 Receptor 64% 66.405uM NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) CLOTRIMAZOLE Protein Tyrosine Kinase, HER2 Receptor 64% 66.405uM NoneNone View
epidermal growth factor receptor CLOTRIMAZOLE Protein Tyrosine Kinase, EGF Receptor 64% 69.421uM NoneNone View
Protein-tyrosine kinase, Fyn CLOTRIMAZOLE Protein Tyrosine Kinase, Fyn 64% 31.851uM NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 TRETINOIN Adrenergic, Norepinephrine Transporter 64% NoneNone NoneNone View
adrenergic receptor, alpha 1b ATROPINE Adrenergic alpha1B 64% NoneNone NoneNone View
thromboxane A synthase 1 THIMEROSAL Thromboxane Synthetase 64% NoneNone NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) THIMEROSAL Thromboxane Synthetase 64% NoneNone NoneNone View
adenosine A2a receptor BENZBROMARONE Adenosine A2A 64% NoneNone NoneNone View
opioid receptor, sigma 1 TIMOLOL Sigma1 64% NoneNone NoneNone View
Cytochrom P450-1A2 monooxygenase FLUPHENAZINE CYP450-1A2 Inhibition 64% NoneNone NoneNone View
mitogen activated protein kinase 14 CAFFEIC ACID PHENETHYL ESTER Protein Serine/Threonine Kinase, p38alpha 64% NoneNone NoneNone View
mitogen-activated protein kinase 14 CAFFEIC ACID PHENETHYL ESTER Protein Serine/Threonine Kinase, p38alpha 64% NoneNone NoneNone View
dopamine receptor 2 DOXEPIN Dopamine D2L 64% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2B MC 288769 Serotonin 5-HT2B 64% 20.93uM 13.319uM View
matrix metallopeptidase 9 TRIAMTERENE Protease, Matrix Metalloprotease-9 (MMP-9) 64% NoneNone NoneNone View
matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) TRIAMTERENE Protease, Matrix Metalloprotease-9 (MMP-9) 64% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2C GENISTEIN Serotonin 5-HT2C 64% 14.91uM 7.806uM View
cholinergic receptor, muscarinic 4 EPERISONE Muscarinic M4 64% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 MYCOPHENOLATE MOFETIL Serotonin Transporter 64% NoneNone NoneNone View
adrenergic receptor, alpha 1d (Non-specific probe) VERAPAMIL Adrenergic alpha1D 64% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha VINORELBINE Sodium Channel, Site 2 64% 5.202uM 4.746uM View
sodium channel, voltage-gated, type X, alpha VINORELBINE Sodium Channel, Site 2 64% 5.202uM 4.746uM View
sodium channel, voltage-gated, type IX, alpha VINORELBINE Sodium Channel, Site 2 64% 5.202uM 4.746uM View
sodium channel, voltage gated, type VIII, alpha VINORELBINE Sodium Channel, Site 2 64% 5.202uM 4.746uM View
sodium channel, voltage-gated, type VII, alpha VINORELBINE Sodium Channel, Site 2 64% 5.202uM 4.746uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) VINORELBINE Sodium Channel, Site 2 64% 5.202uM 4.746uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) ETHINYLESTRADIOL Sodium Channel, Site 2 61% 22.482uM 20.156uM View
sodium channel, nonvoltage-gated 1 alpha ETHINYLESTRADIOL Sodium Channel, Site 2 61% 22.482uM 20.156uM View